Virologic effect and hepatotoxicity of BCR::ABL1 tyrosine kinase inhibitors in cancer patients with chronic hepatitis C virus infection: A prospective study.

Leuk Res

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

Published: December 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.leukres.2024.107597	DOI Listing

Publication Analysis

virologic hepatotoxicity

hepatotoxicity bcrabl1

bcrabl1 tyrosine

tyrosine kinase

kinase inhibitors

inhibitors cancer

cancer patients

patients chronic

chronic hepatitis

hepatitis virus

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!